CDKN2A and neoplasm: Interestingly, they detected a CDKN2A mutation in ctDNA that was absent in primary tumor tissue, highlighting potential limitations of tumor‐informed ctDNA panel approaches, as proposed by Kogo et al., despite their favorable performance metrics.